In humans, HSC kinetic data derived from the clonal tracking of their activityin vivo have been obtained from gene therapy clinical trials for adenosine deaminase (ADA) deficient-SCID and Wiskott-Aldrich syndrome (WAS). This evidence concerns the gene ADA and Wiskott-Aldrich syndrome.